SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 1, 2018, Pages 115-117

Emergence of myasthenia gravis with myositis in a patient treated with pembrolizumab for thymic cancer

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85040690617 PISSN: 17386586 EISSN: 20055013 Source Type: Journal
DOI: 10.3988/jcn.2018.14.1.115 Document Type: Letter

Times cited : (24)

References (9)

1
- 84922339585
- Pembrolizumab: PD-1 inhibition as a therapeutic strategy in cancer
- McDermott J, Jimeno A. Pembrolizumab: PD-1 inhibition as a therapeutic strategy in cancer. Drugs Today (Barc) 2015;51:7-20.
- (2015) Drugs Today (Barc) , vol.51 , pp. 7-20
- McDermott, J.¹ Jimeno, A.²

2
- 84977090451
- Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma
- Vallet H, Gaillet A, Weiss N, Vanhaecke C, Saheb S, Touitou V, et al. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma. Ann Oncol 2016;27:1352-1353.
- (2016) Ann Oncol , vol.27 , pp. 1352-1353
- Vallet, H.¹ Gaillet, A.² Weiss, N.³ Vanhaecke, C.⁴ Saheb, S.⁵ Touitou, V.⁶

3
- 84964389238
- Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
- Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 2016;60:210-225.
- (2016) Eur J Cancer , vol.60 , pp. 210-225
- Zimmer, L.¹ Goldinger, S.M.² Hofmann, L.³ Loquai, C.⁴ Ugurel, S.⁵ Thomas, I.⁶

4
- 84975078639
- Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab
- Lau KH, Kumar A, Yang IH, Nowak RJ. Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab. Muscle Nerve 2016;54:157-161.
- (2016) Muscle Nerve , vol.54 , pp. 157-161
- Lau, K.H.¹ Kumar, A.² Yang, I.H.³ Nowak, R.J.⁴

5
- 84982171125
- Myasthenia gravis exacerbation associated with pembrolizumab
- Zhu J, Li Y. Myasthenia gravis exacerbation associated with pembrolizumab. Muscle Nerve 2016;54:506-507.
- (2016) Muscle Nerve , vol.54 , pp. 506-507
- Zhu, J.¹ Li, Y.²

6
- 85009786708
- Myasthenia triggered by immune checkpoint inhibitors: New case and litera- ture review
- Gonzalez NL, Puwanant A, Lu A, Marks SM, Živković SA. Myasthenia triggered by immune checkpoint inhibitors: new case and litera- ture review. Neuromuscul Disord 2017;27:266-268.
- (2017) Neuromuscul Disord , vol.27 , pp. 266-268
- Gonzalez, N.L.¹ Puwanant, A.² Lu, A.³ Marks, S.M.⁴ Živković, S.A.⁵

7
- 85018320215
- Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm
- Haddox CL, Shenoy N, Shah KK, Kao JC, Jain S, Halfdanarson TR, et al. Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm. Ann Oncol 2017;28:673-675.
- (2017) Ann Oncol , vol.28 , pp. 673-675
- Haddox, C.L.¹ Shenoy, N.² Shah, K.K.³ Kao, J.C.⁴ Jain, S.⁵ Halfdanarson, T.R.⁶

9
- 85021263317
- Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
- Makarious D, Horwood K, Coward JIG. Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors. Eur J Cancer 2017;82: 128-136.
- (2017) Eur J Cancer , vol.82 , pp. 128-136
- Makarious, D.¹ Horwood, K.² Coward, J.I.G.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.